GlaxoSmithKline (GSK) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of over 4.3 billion ordinary shares, with a total of approximately 4.1 billion voting rights available. This information is crucial for shareholders calculating their interest in the company as per regulatory guidelines.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.
